HomePress Releases Press Releases Whether it’s a new product enabling ground-breaking research, a strategic partnership with a customer, or a charitable partnership that supports our mission, we’ve always got something going on. Below you’ll find our most recent press releases as well as a filter to further streamline your search. CONTACT For journalist inquiries only, contact: Rachel Bloom-Baglin Phone: +1 978-436-1725 rachel.bloom-baglin@milliporesigma.com Nov 11, 2021 Merck Signs Strategic Agreement with GI Innovation to Facilitate Biomedicine Development in Korea Merck announced that the Life Science business sector signed a Memorandum of Understanding with local bio-venture company GI Innovation. Nov 09, 2021 Merck Announces Leadership Changes in France Merck, a leading science and technology company, today announced the retirement of Jean-Phillipe Maurer as Head of Molsheim Operations, effective December 1. Nov 03, 2021 Merck to Support SaudiVax in Becoming First Developer and Manufacturer of Halal Vaccines and Biotherapeutics in Saudi Arabia Merck today announced that the Life Science business sector will support SaudiVax Ltd. to design a manufacturing facility to localize manufacturing of biologics and vaccines for the MENA region. Oct 28, 2021 Merck Drives New Innovation & Adds Capacity to Advance Next Generation Antibody-drug Conjugate (ADC) Therapies Merck today announced that its Life Science business sector has launched new technology and expanded capacity to advance ADC therapies. Oct 21, 2021 Merck's M Lab™ Collaboration Center in Songdo Celebrates Fifth Anniversary with Virtual Open House Korea M Lab™ Collaboration Center marks five years of continuous operation, recording over 540 collaborations and trainings, benefitting over 1,000 biopharmaceutical and biotech customers Oct 20, 2021 Merck Collaborates with Bio-valley (Beijing) Technology Co., LTD on Biotechnology R&D Platform to Support Talent Development in China Merck today announced a collaboration with Bio-valley (Beijing) Technology Co., LTD (Bio-valley) to establish technical talent training programs for China’s biopharmaceutical industry. Oct 12, 2021 Merck Completes New Viral Vector Contract Development Manufacturing Facility for Gene Therapy Merck, a leading science and technology company, today announced the opening of its second Carlsbad, California-based facility, significantly expanding its global CDMO footprint. Oct 05, 2021 Merck Announces that its Life Science Business Sector Has Signed an Agreement Licensing its Patented CRISPR-Cas9 Technology to California-based Cellecta, Inc. Merck, a leading science and technology company, today announced that its Life Science business sector has signed an agreement licensing its patented CRISPR-Cas9 technology to California-based Cellecta, Inc. Aug 27, 2021 Merck funds Indian Institute of Technology (IIT) Bombay for Covid-19 research Merck today announced a donation of INR 1.7crore (194,000€) over two years to the Indian Institute of Technology (IIT), Bombay to support the development of clinical tests for Covid-19 disease severity assessment. Jul 05, 2021 Merck’s Tokyo M Lab™ Collaboration Center Commemorates Fifth Anniversary of Supporting Science Community in Japan Lab marks five years of continuous operation and 400+ activities, benefitting more than 10,000 customers. Jun 23, 2021 Merck Receives Patent for Improved CRISPR Genome-Editing Method in Japan Merck today announced that the Japanese Patent Office has issued a formal notice allowing the company’s patent application for its proxy-CRISPR technology. Jun 09, 2021 Merck Holds Joint Seminar with KOFWST to Address Safe Management of Research Labs Merck will hold a collaborative seminar with the Korea Federation of Women’s Science and Technology Associations (KOFWST) about ways to ensure a safe and healthy laboratory environment for pregnant scientists. May 26, 2021 Merck Accelerates Scale Up of Lipids to Meet Covid-19 Demand To meet the high demand for lipids, a key component of mRNA-based vaccines and therapeutics, {HCompany} has launched a new, high-purity synthetic cholesterol product, nine months ahead of schedule. May 20, 2021 Merck Improves Lab Productivity Through Faster and More Sustainable Nucleic Acid Purification Merck introduced a new solution improving productivity in the lab through a more flexible and streamlined nucleic acid purification process — GenElute™-E Single Spin purification kits. May 18, 2021 Merck Announces VectorY as Winner of its Advance Biotech Grant Merck today announced that VectorY has been selected as the European winner of its 2021 Advance Biotech Grant Program. May 04, 2021 Merck Partners with Topco Scientific Co. to Increase Greener Manufacturing Materials Usage Merck today announced a partnership with Topco Scientific Co. (TSC), a leading semiconductor supplier in Taiwan, to increase the use of more sustainable materials for the electronics industry. Mar 31, 2021 Merck Establishes Collaboration Laboratory with Universitas Indonesia to Advance Life Science Research Merck today announced a strategic partnership with the Universitas Indonesia (FMIPA-UI) to establish the first Collaboration Laboratory between the company and the university. Mar 17, 2021 Merck Accelerates European Expansion Plans for Single-use Products Critical to Manufacturing Vaccines and Lifesaving Therapies Merck will add a single-use assembly production unit at its Life Science Center in Molsheim, France. Mar 15, 2021 Merck Brings New Renewable Energy to the Grid through Virtual Power Purchase Agreement with Enel Green Power As part of its ongoing commitment to renewable energy, Merck, a leading science and technology company, has signed a 12-year, off-site, virtual power purchase agreement (VPPA) with Enel Green Power for the construction of a future wind and storage project Feb 15, 2021 Merck Enhances Design for Sustainability Framework, Offers Customers Data-Driven Insights for Greener Solutions Merck has launched an enhanced Design for Sustainability (DfS) framework, a unique approach to holistically integrate sustainability into Life Science products, systems and services. Feb 04, 2021 Merck Continues Commitment to Science Education and Equity with Leading Non-Profits Around the World Building on its commitment to accelerate scientific research and science education, Merck has announced seven expanded partnerships with leading nonprofit organizations across the world. Jan 07, 2021 Merck Acquires AmpTec to Expand mRNA Capabilities for Vaccines, Treatments, and Diagnostics Merck today announced the acquisition of AmpTec, a leading Hamburg, Germany-based, mRNA contract development and manufacturing organization (CDMO). Dec 07, 2020 Merck Expands Life Science Production Capacities in the United States Merck today announced the broadening of its manufacturing footprint with a combined € 40 million investment at its production facilities in Danvers, Massachusetts, and Jaffrey, New Hampshire, USA. Nov 20, 2020 Massachusetts-based Businesses of Merck KGaA, Darmstadt, Germany Named to The Boston Globe’s ‘Top Places to Work’ List Nov 10, 2020 Merck’s Latest Technologies Earn Industry Recognition for Accelerating Bioprocessing 4.0 Merck today announced that its first-to-market Blazar™ platform from the BioReliance® portfolio has won R&D 100 and CPhI Awards for its ability to reduce testing times by up to 80 percent. Nov 07, 2020 Merck and Transcenta Collaborate to Advance Continuous Biomanufacturing, Make the ‘Facility of the Future’ a Reality Merck and Transcenta, a global biotherapeutics company, have announced a strategic technology collaboration to implement continuous manufacturing for protein therapeutics. Nov 06, 2020 Merck to Collaborate with Donghao Lansheng to Pilot New Import Policy in China Oct 18, 2020 Merck Awards Grant to Combined Therapeutics for its Nucleic Acid Platform That, with Virotherapy, Targets Liver Cancer Merck today announced that Combined Therapeutics Inc., Cambridge, Massachusetts, USA, has been selected as the North American winner of its 2020 Advance Biotech Grant Program. Oct 13, 2020 Merck’s New VirusExpress™ Platform Speeds Development of Cell and Gene Therapies Merck has bolstered its viral vector manufacturing capabilities with the launch of its VirusExpress™ Lentiviral Production Platform. Oct 12, 2020 Merck Licenses CRISPR Genome-Editing Technology to PanCELLa and Takara Bio USA Merck today announced that it has signed agreements licensing its CRISPR technology to two companies — PanCELLa, a cell therapy firm based in Toronto, Canada and Takara Bio USA, Inc., a biotechnology company based in Mountain View, California, USA. Oct 08, 2020 Merck Supporting Innovation in China with D1Med Collaboration Merck is collaborating with D1Med, a Shanghai-based biopharmaceutical start-up precision-medical company, to accelerate production of D1Med’s 3D cell culture technology applications used in the drug discovery process. Oct 07, 2020 Merck Celebrates Topping-Out Ceremony for New Membrane Production Plant Merck today celebrated the topping-out ceremony for its new membrane production plant in Darmstadt, Germany. Oct 06, 2020 Merck Inaugurates New, Upgraded Onsite Industrial Water Treatment Plant Merck today inaugurated a new $14.4 million industrial water treatment plant at its Jaffrey, New Hampshire, location. Sep 09, 2020 Merck Announces € 59 Million Antibody-Drug Conjugate Manufacturing Expansion Merck today announced a € 59 million expansion of its HPAPI and ADC manufacturing capabilities and capacity at its facility near Madison, Wisconsin, USA. Sep 03, 2020 Merck today announced the donation of research instruments and materials worth IDR 1.2 billion (€ 74,000) to support the efforts of Eijkman Institute for Molecular Biology, Indonesia Jul 29, 2020 Merck’s DOZN™ Green Chemistry Tool Named Top Project of the Year by Environment + Energy Leader Merck today announced that it won a Top Project of the Year award from Environment + Energy Leader for its DOZN™ system. Jul 15, 2020 Merck Invests € 18 Million in New Life Science Laboratory in Switzerland Merck has announced plans to build a new, € 18 million laboratory facility in Buchs, Switzerland to support the company’s rapidly growing reference materials business. Jul 10, 2020 Merck Opens its Largest M Lab™ Collaboration Center in Shanghai Merck today opened its M Lab™ Collaboration Center in Shanghai, the company’s largest of nine centers worldwide. Jul 06, 2020 Merck Announces VAR2 Pharmaceuticals as Winner of its Advance Biotech Grant Merck today announced that VAR2 Pharmaceuticals has been selected as the European winner of its 2020 Advance Biotech Grant Program. Jul 01, 2020 New Report Identifies Paths to Pandemic Resilience A new report details potential paths to solutions to overcoming the global Covid-19 crisis and ways to prepare for or even prevent a future pandemic. Jun 30, 2020 Merck Advances Bioprocessing Capabilities with Raman Technology Sensor Acquisition Merck today enhanced its advanced bioprocess portfolio through the acquisition of RESOLUTION Spectra Systems, a Meylan, France-based leader in bioprocess analytical monitoring. Jun 10, 2020 Merck and 10x Genomics Launch Powerful New Option for CRISPR Research Merck and 10x Genomics, Inc., a single cell and spatial genomics technologies company, today announced that they have developed a powerful new option for biological experiments. May 27, 2020 Merck and Baylor College of Medicine Collaborate to Advance a Vaccine Manufacturing Platform to Fight Covid-19 Merck and Baylor College of Medicine, Houston, Texas, USA, today announced an extension of their ongoing collaboration to advance a manufacturing platform to fight Covid-19, designed to accelerate transition to P May 11, 2020 Merck Granted U.S. Patents for Foundational CRISPR-Cas9 Technology Merck today announced that two of its CRISPR-Cas9-assisted genome-editing patents have been allowed in the United States. Apr 30, 2020 Merck Accelerates Readiness of Bioprocessing Facility of the Future Merck today unveiled the next component of its BioContinuum™ Platform, the Bio4C™ Software Suite, creating a first-of-its-kind ecosystem that combines process control, analytics and plant-level automation. Apr 21, 2020 Merck Boosts Commercial Viral Vector and Gene Therapy Manufacturing Capacity Merck, a leading science and technology company, today announced a second Carlsbad, California, U.S.A.-based facility for its BioReliance® viral and gene therapy service offering. Apr 14, 2020 Merck Supports Jenner Institute to Reach First Milestone in Covid-19 Vaccine Manufacturing Merck and The Jenner Institute today announced that the Jenner Institute has laid the foundation for large-scale production of its Covid-19 vaccine candidate, ChAdOx1 nCoV-19. Apr 07, 2020 Merck Awarded Second U.S. Patent for CRISPR Gene-Editing Technology Merck today announced that the United States Patent and Trademark Office has granted the company’s patent for CRISPR-chrom technology. Mar 02, 2020 Merck’s New LANEXO™ System to Improve Scientists’ Productivity in the Lab Merck today launched its LANEXO™ Lab Inventory, Safety and Compliance Management System, a new digital laboratory informatics solution designed to drastically reduce time in labs and improve data quality and traceability. Feb 17, 2020 Merck to Manufacture Elypta’s Liquid Biopsy Kits Merck today announced that it has been selected by Swedish molecular diagnostics firm Elypta as the contract manufacturer for Elypta’s clinical diagnostic liquid biopsy kits. Feb 10, 2020 Merck’s New BrightLab™ Cloud-hosted Software Brings IoT to R&D Merck today introduced its BrightLab™ cloud-based inventory management and instrument connectivity platform for research scientists. Jan 10, 2020 Merck and CSIR-IMTECH Open High-tech Skill Development Center Merck today announced the opening of new, non-profit center where Indian students and researchers can learn the latest genome-editing and single-molecule biomolecule biomarker detection technologies from Merck experts. Dec 18, 2019 Merck Licenses Foundational CRISPR Integration Technology to Promega Merck today announced that it has signed a license agreement providing Promega Corp., a global life science manufacturer based in Madison, Wisconsin, USA access to Merck’s foundational CRISPR intellectual property. Nov 25, 2019 Japan and Singapore Grant CRISPR Patents to Merck Merck today announced that the Japan Patent Office and the Intellectual Property Office of Singapore have each allowed the company’s patent application for the use of paired CRISPR nickases, bringing Merck’s number of patents to 22 worldwide. Nov 18, 2019 Merck Expands in Gillingham, UK, Boosts Distribution Capabilities Merck today announced the completion of a £9 million expansion to its Gillingham distribution centre. Nov 17, 2019 Merck Wins R&D 100 Award for First-to-Market Biopharma Purification Innovation Merck today announced it has received a prestigious R&D 100 Award for its Eshmuno® CP-FT Resin, a first-to-market product used in biopharmaceutical manufacturing. Nov 11, 2019 Merck Licenses CRISPR Gene-Editing Technology to Evotec Merck today announced that it has signed a license agreement providing Evotec SE access to Merck’s foundational CRISPR intellectual property. Oct 18, 2019 Merck Becomes the First to Use Acoustic Technology for Cell Therapy Manufacturing Merck today announced it has acquired FloDesign Sonics, of Wilbraham, Massachusetts, USA, developer of a unique acoustic cell processing platform for the industrialization of cell and gene therapy manufacturing. Sep 19, 2019 Merck Launches First Flagship Store on Alibaba’s 1688.com to Improve the Customer Experience Merck has launched its official flagship store (merckls.1688.com) on Alibaba’s 1688.com. Sep 18, 2019 Merck Expands BioReliance® Viral Clearance Offering in Singapore, Saving Customers Time Merck today announced an expansion of its Singapore biosafety testing laboratory services. Aug 19, 2019 Merck Granted 20 CRISPR Patents Total Worldwide Merck today announced that the European, Israeli, South Korean and U.K. intellectual property offices have issued formal notices allowing seven additional Merck patent application claims covering CRISPR gene-editing technology. Aug 05, 2019 Merck Acquires BSSN Software to Accelerate Customers’ Digital Transformation in the Lab Merck has acquired BSSN Software, a Darmstadt, Germany-based laboratory informatics company that makes data more readily accessible for ease of integration, collaboration, ana Jul 24, 2019 Merck to Provide BioReliance® End-to-End Solutions to Phanes Therapeutics Merck today announced the signing of a non-binding Memorandum of Understanding (MoU) with Phanes Therapeutics, Inc. (Phanes) for a collaboration on the development and manufacture of biologics for the treatment of solid tumors. Jul 18, 2019 Merck and Broad Institute Announce CRISPR License Framework to Encourage Innovation Merck and the Broad Institute of MIT and Harvard (Boston, Massachusetts) today announced an agreement to offer non-exclusive licenses to CRISPR intellectual property (IP) under their respective control for use in commercial research and product developmen Jun 20, 2019 Merck Introduces Mobile Laboratory to Promote Protein Research Merck today announced a national campus tour in China for the company’s first mobile protein research laboratory. Jun 19, 2019 Merck’s Massachusetts-based Business Sectors Named ‘Best Places to Work’ by Boston Business Journal Merck KGaA, Darmstadt, Germany, today announced that its Massachusetts-based business sectors, MilliporeSigma, EMD Serono and EMD Performance Materials, have been named to the Boston Business Journal’s annual “Best Places to Work". May 29, 2019 Merck Awards Grants to Biotechs Focused on Traumatic Brain Injury, Vaccine Development, and Chronic Pain Merck today announced the winners of its Advance Biotech Grant program in North America during its Biotech Start-up Summit at the Cambridge Innovation Center (Massachusetts, U.S.). May 28, 2019 Merck Announces Winners of School Science Competition Merck today announced that students from St Aloysius’ College in Carrigtwohill have won the company’s 2019 School Science Competition, now in its 15th year. May 27, 2019 Merck Expands Cell Culture Media Production Facility in Irvine Merck today announced the completion of a £2.7 million expansion to its Irvine biopharmaceutical production facility. May 22, 2019 Experts Discuss Decentralized Manufacturing to Tackle Neglected Tropical Diseases and Promote Universal Health Coverage at World Health Assembly Event Merck today hosted a panel discussion on the occasion of the 72nd World Health Assembly in Geneva, Switzerland. May 20, 2019 Merck Joins TRANSVAC2 Program to Advance Vaccine Development and Manufacturing Merck today announced its participation in a collaboration with the Vaccine Formulation Institute and the European Vaccine Initiative. May 07, 2019 Merck Announces Winner of First Retrosynthetic Reaction Prediction Contest Merck today announced that MDL, a team from Beijing University, has won the company’s first Retrosynthetic Reaction Prediction Contest. Apr 30, 2019 Merck and India’s Food Safety and Standards Authority Partner on Skill Development in Food Safety Merck today announced the handover of a fully equipped microbiological testing laboratory to the Food Safety and Standards Authority of India (FSSAI). Apr 23, 2019 Merck Introduces New Greener Solvent, Cyrene™ Merck today launched Cyrene™ — a sustainable dipolar aprotic solvent, produced in two steps from a renewable cellulose source. Apr 03, 2019 Merck Recognized with INTERPHEX Exhibitor Award for Best New Product Merck today announced that it has won an INTERPHEX Exhibitor Award for a new innovation in advancing next-generation bioprocessing. Apr 02, 2019 Merck Elevates its BioContinuum™ Platform Strategy to Deliver ‘ContiGuous’ Bioprocessing Merck today unveiled its BioContinuum™ Buffer Delivery Platform, a new building block in the BioContinuum™ Platform for next-generation bioprocessing, at INTERPHEX in New York City. Mar 20, 2019 Merck Opens First M Lab™ Collaboration Center in Europe Merck today officially opened its new M Lab™ Collaboration Center in Molsheim, France. Mar 19, 2019 Merck To Collaborate with GenScript to Accelerate Cell and Gene Therapy Industrialization in China Merck today announced the signing of a non-binding Memorandum of Understanding with Chinese biotech company GenScript for a strategic alliance focusing on plasmid and viral vector manufacturing. Mar 17, 2019 Merck’s Milli-Q® Connect Combines Deep Water Purification Expertise with Cloud-based Digital Technology Merck today announced a new cloud-based, remote lab water service and monitoring capability available on all Milli-Q® CLX 7000 clinical water purification systems. Mar 14, 2019 Zhejiang University Joins Merck’s CRISPR Core Partnership Program Merck today announced a CRISPR core partnership with Zhejiang University in Hangzhou, China. Mar 07, 2019 Merck Brings Science Education to Students Across North America with Curiosity Cube® Mobile Science Lab Mar 04, 2019 Merck Awarded Canadian CRISPR Nickase Patent for Foundational Genome-Editing Technology Merck today announced that the Canadian Patent Office has allowed Merck’s patent application directed to the use of paired CRISPR nickases in eukaryotic cells. Feb 19, 2019 Merck Receives First U.S. Patent for Improved CRISPR Genome-Editing Method Merck today announced that the U.S. Patent and Trademark Office has issued a formal notice allowing MilliporeSigma’s patent application directed to its proxy-CRISPR technology. Feb 04, 2019 Merck Awards Grants to Biotechs Tackling Cancer and Cardiovascular Disease Merck today announced the winners of its Advance Biotech Grant program in Europe. The grant is given to small- and mid-size biotechnology companies that need funding and expertise to get their therapies to market. Jan 14, 2019 Merck Wins Life Science Industry Award® for Best Use of Social Media Merck today announced that it has been recognized by BioInformatics LLC with a 2018 Life Science Industry Award® for best use of social media. Dec 18, 2018 Merck Collaborates with Kuraray to Improve Drug Delivery Merck today announced it has extended and expanded its collaboration with Kuraray Europe to exclusively supply pharmaceutical polyvinyl alcohol (PVA) grades and improvements to benefit the pharmaceutical market. Dec 10, 2018 Merck and genOway Form CRISPR/Cas9 Strategic Alliance to Develop Rodent Models Merck today announced a strategic alliance in the CRISPR/Cas9 rodent model market with France-based biotechnology company genOway. © 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved. Reproduction of any materials from the site is strictly forbidden without permission. Site Use Terms|Privacy Policy|General Terms and Conditions of Sale|Copyright Consent